"Impetigo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.
| Descriptor ID |
D007169
|
| MeSH Number(s) |
C01.252.410.868.820.504 C01.252.410.890.485 C01.252.825.770.360 C01.539.800.720.770.360 C17.800.838.765.770.360
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Impetigo".
Below are MeSH descriptors whose meaning is more specific than "Impetigo".
This graph shows the total number of publications written about "Impetigo" by people in this website by year, and whether "Impetigo" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 0 | 1 |
| 1992 | 1 | 0 | 1 |
| 1993 | 1 | 0 | 1 |
| 1995 | 2 | 0 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2002 | 9 | 1 | 10 |
| 2003 | 7 | 2 | 9 |
| 2004 | 2 | 1 | 3 |
| 2005 | 4 | 3 | 7 |
| 2006 | 4 | 1 | 5 |
| 2007 | 6 | 0 | 6 |
| 2008 | 4 | 1 | 5 |
| 2009 | 4 | 0 | 4 |
| 2010 | 8 | 1 | 9 |
| 2011 | 4 | 4 | 8 |
| 2012 | 2 | 2 | 4 |
| 2013 | 4 | 5 | 9 |
| 2014 | 7 | 1 | 8 |
| 2015 | 9 | 4 | 13 |
| 2016 | 10 | 0 | 10 |
| 2017 | 5 | 3 | 8 |
| 2018 | 10 | 2 | 12 |
| 2019 | 8 | 2 | 10 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Impetigo" by people in Profiles.
-
A case of goggle-mask-related impetigo at the time of the COVID-19 pandemic. Dermatol Ther. 2020 Jul; 33(4):e13636.
-
Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin. Clin Infect Dis. 2020 04 10; 70(8):1591-1595.
-
Wolf's Isotopic Response after Herpes Zoster Infection: A Study of 24 New Cases and Literature Review. Acta Derm Venereol. 2019 Oct 01; 99(11):953-959.
-
Prevalence of scabies and impetigo in the Solomon Islands: a school survey. BMC Infect Dis. 2019 Sep 13; 19(1):803.
-
Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo. Viruses. 2019 08 22; 11(9).
-
Impetigo incidence and treatment: a retrospective study of Dutch routine primary care data. Fam Pract. 2019 07 31; 36(4):410-416.
-
Topical Ozenoxacin Cream 1% for Impetigo: A Review J Drugs Dermatol. 2019 Jul 01; 18(7):655-661.
-
Mass Drug Administration for Scabies - 2 Years of Follow-up. N Engl J Med. 2019 07 11; 381(2):186-187.
-
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. Lancet Infect Dis. 2019 05; 19(5):510-518.
-
Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo. Clin Infect Dis. 2019 03 05; 68(6):927-933.